[1]何丽杰.防己黄芪汤加减治疗原发性肾病综合征水肿期的疗效分析[J].医学信息,2018,31(12):151-152.[doi:10.3969/j.issn.1006-1959.2018.12.048]
　HE Li-jie.Therapeutic Efficacy of Fangji Huangqi Decoction in Treating Nephrotic Syndrome Edema Phase[J].Journal of Medical Information,2018,31(12):151-152.[doi:10.3969/j.issn.1006-1959.2018.12.048]
点击复制

防己黄芪汤加减治疗原发性肾病综合征水肿期的疗效分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年12期
页码:
151-152
栏目:
中医中药
出版日期:
2018-06-15

文章信息/Info

Title:
Therapeutic Efficacy of Fangji Huangqi Decoction in Treating Nephrotic Syndrome Edema Phase
文章编号:
1006-1959（2018）12-0151-02
作者:
何丽杰
黑龙江省佳木斯市中医院中医内科，黑龙江 佳木斯 154002
Author(s):
HE Li-jie
Department of Traditional Chinese Medicine,Jiamusi Traditional Chinese Medicine Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
原发性肾病综合征; 防己黄芪汤加减; 水肿期
Keywords:
Key words：Nephrotic syndrome; Fangji Huangqi decoction; Edema phase
分类号:
R256.5
DOI:
10.3969/j.issn.1006-1959.2018.12.048
文献标志码:
A
摘要:
目的 对原发性肾病综合征水肿期患者接受防己黄芪汤加减治疗的临床效果，为临床中医用药治疗提供依据。 方法 根据2016年1月~12月我院接收的原发性肾病综合征水肿期患者36例开展研究，将患者按照数字随机法分成对照组和观察组，每组18例。为对照组患者提供常规西医治疗方式，为观察组患者提供常规西医治疗和黄芪汤增减治疗，对两组的治疗有效率，治疗前后24 h尿蛋白定量进行对比。 结果 治疗后对照组有效率70.00%，低于观察组95.00%。差异有统计学意义（P＜0.05）,对照组治疗前24 h尿蛋白定量（1.36±0.24）g/L，治疗后（0.64±0.13）g /24 h，观察组治疗前为（1.38±0.28）g/L，治疗后为（0.22±0.14）g/24 h；两组治疗前对比，差异无统计学意义（P＞0.05），两组治疗后对比，差异有统计学意义（P＜0.05）。结论 原发性肾病综合征水肿期患者接受防己黄芪汤加减治疗效果明显，安全可靠，患者的水肿期症状得到缓解。
Abstract:
Abstract：Objective To evaluate the clinical effect of the treatment of patients with edema of nephritic syndrome treated with decoction of Fangji Huangyu Decoction,and to provide evidence for the clinical treatment of medical drugs.Methods 36 patients with edema stage of nephrotic syndrome received in our hospital from January to December in 2016 were studied.The patients were divided into control group and observation group according to the digital randomization method.Each group contained 18 cases,patients in the control group were provided with routine western medicine treatment.To provide routine western medicine treatment and Huangqi Decoction for the observation group,the effective rate of the two groups was compared,and the urine protein level of 24 h before and after treatment was compared.Results The effective rate of the control group after treatment was 70.00%,which was lower than the observation group 95.00%,the difference was statistically significant(P<0.05).The 24 h urine protein in the control group was (1.36±0.24)g/L before treatment and(0.64±0.13)g/24 h after treatment.The observation group was(1.38±0.28)g/L before treatment and (0.22±0.14)g/24 h after treatment.There was no significant difference between the two groups before treatment(P>0.05),and there was a significant difference between the two groups after treatment(P<0.05).Conclusion The treatment of patients with nephrotic syndrome during edema stage is effective,safe and reliable,and the symptoms of edema period are relieved.

参考文献/References:

[1]林坚.中西医结合治疗原发性肾病综合征临床观察[J].中华中医学刊,2012,30(3)：658-659.
[2]王柳.阿托伐他汀钙与低分子肝素联合激素治疗原发性肾病综合征的疗效对比观察[J].中国医药指南,2011,9(21):91-92.
[3]窦健全.奥扎格雷钠治疗原发性肾病综合征患者的临床疗效[J].临床医学,2013,33(6)：71-72.
[4]崔向飞.黄葵胶囊联合泼尼松治疗原发性肾病综合征疗效分析[J].中国中西医结合肾病杂志,2011,12(1)：71.
[5]钟发群．黄葵胶囊联合泼尼松治疗原发性肾病综合征疗效分析[J].中国医学创新，2012，9(2)：27-28.

相似文献/References:

[1]王 丽.金水宝片对原发性肾病综合征患者血液流变学的影响[J].医学信息,2019,32(18):156.[doi:10.3969/j.issn.1006-1959.2019.18.054]
　WANG Li.Effect of Jinshuibao Tablet on Hemorheology in Patients with Primary Nephrotic Syndrome[J].Journal of Medical Information,2019,32(12):156.[doi:10.3969/j.issn.1006-1959.2019.18.054]
[2]解艳欢.原发性肾病综合征免疫发病机制研究[J].医学信息,2023,36(20):189.[doi:10.3969/j.issn.1006-1959.2023.20.040]
　XIE Yan-huan.Research on Immune Pathogenesis of Primary Nephrotic Syndrome[J].Journal of Medical Information,2023,36(12):189.[doi:10.3969/j.issn.1006-1959.2023.20.040]

更新日期/Last Update: 2018-06-15